| pubmed-article:19795521 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:19795521 | lifeskim:mentions | umls-concept:C0015965 | lld:lifeskim |
| pubmed-article:19795521 | lifeskim:mentions | umls-concept:C0018787 | lld:lifeskim |
| pubmed-article:19795521 | lifeskim:mentions | umls-concept:C0220912 | lld:lifeskim |
| pubmed-article:19795521 | lifeskim:mentions | umls-concept:C0597198 | lld:lifeskim |
| pubmed-article:19795521 | lifeskim:mentions | umls-concept:C0205216 | lld:lifeskim |
| pubmed-article:19795521 | lifeskim:mentions | umls-concept:C0872291 | lld:lifeskim |
| pubmed-article:19795521 | lifeskim:mentions | umls-concept:C0748972 | lld:lifeskim |
| pubmed-article:19795521 | lifeskim:mentions | umls-concept:C0439590 | lld:lifeskim |
| pubmed-article:19795521 | lifeskim:mentions | umls-concept:C0220913 | lld:lifeskim |
| pubmed-article:19795521 | pubmed:issue | 5 | lld:pubmed |
| pubmed-article:19795521 | pubmed:dateCreated | 2009-10-28 | lld:pubmed |
| pubmed-article:19795521 | pubmed:abstractText | To investigate if anti-Ro/SSA antibody-exposed fetuses with prolonged atrioventricular (AV) time intervals also have prolongation of the isovolumetric contraction time (ICT). | lld:pubmed |
| pubmed-article:19795521 | pubmed:language | eng | lld:pubmed |
| pubmed-article:19795521 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:19795521 | pubmed:citationSubset | IM | lld:pubmed |
| pubmed-article:19795521 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:19795521 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:19795521 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:19795521 | pubmed:month | Nov | lld:pubmed |
| pubmed-article:19795521 | pubmed:issn | 1469-0705 | lld:pubmed |
| pubmed-article:19795521 | pubmed:author | pubmed-author:BremmeKK | lld:pubmed |
| pubmed-article:19795521 | pubmed:author | pubmed-author:BergmanGG | lld:pubmed |
| pubmed-article:19795521 | pubmed:author | pubmed-author:Wahren-Herlen... | lld:pubmed |
| pubmed-article:19795521 | pubmed:author | pubmed-author:EliassonHH | lld:pubmed |
| pubmed-article:19795521 | pubmed:author | pubmed-author:SonessonS-ESE | lld:pubmed |
| pubmed-article:19795521 | pubmed:copyrightInfo | Copyright (c) 2009 ISUOG. Published by John Wiley & Sons, Ltd. | lld:pubmed |
| pubmed-article:19795521 | pubmed:issnType | Electronic | lld:pubmed |
| pubmed-article:19795521 | pubmed:volume | 34 | lld:pubmed |
| pubmed-article:19795521 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:19795521 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:19795521 | pubmed:pagination | 543-9 | lld:pubmed |
| pubmed-article:19795521 | pubmed:meshHeading | pubmed-meshheading:19795521... | lld:pubmed |
| pubmed-article:19795521 | pubmed:meshHeading | pubmed-meshheading:19795521... | lld:pubmed |
| pubmed-article:19795521 | pubmed:meshHeading | pubmed-meshheading:19795521... | lld:pubmed |
| pubmed-article:19795521 | pubmed:meshHeading | pubmed-meshheading:19795521... | lld:pubmed |
| pubmed-article:19795521 | pubmed:meshHeading | pubmed-meshheading:19795521... | lld:pubmed |
| pubmed-article:19795521 | pubmed:meshHeading | pubmed-meshheading:19795521... | lld:pubmed |
| pubmed-article:19795521 | pubmed:meshHeading | pubmed-meshheading:19795521... | lld:pubmed |
| pubmed-article:19795521 | pubmed:meshHeading | pubmed-meshheading:19795521... | lld:pubmed |
| pubmed-article:19795521 | pubmed:meshHeading | pubmed-meshheading:19795521... | lld:pubmed |
| pubmed-article:19795521 | pubmed:meshHeading | pubmed-meshheading:19795521... | lld:pubmed |
| pubmed-article:19795521 | pubmed:meshHeading | pubmed-meshheading:19795521... | lld:pubmed |
| pubmed-article:19795521 | pubmed:meshHeading | pubmed-meshheading:19795521... | lld:pubmed |
| pubmed-article:19795521 | pubmed:meshHeading | pubmed-meshheading:19795521... | lld:pubmed |
| pubmed-article:19795521 | pubmed:meshHeading | pubmed-meshheading:19795521... | lld:pubmed |
| pubmed-article:19795521 | pubmed:year | 2009 | lld:pubmed |
| pubmed-article:19795521 | pubmed:articleTitle | Anti-Ro52/SSA antibody-exposed fetuses with prolonged atrioventricular time intervals show signs of decreased cardiac performance. | lld:pubmed |
| pubmed-article:19795521 | pubmed:affiliation | Department of Woman and Child Health, Karolinska Institutet, Stockholm, Sweden. | lld:pubmed |
| pubmed-article:19795521 | pubmed:publicationType | Journal Article | lld:pubmed |
| pubmed-article:19795521 | pubmed:publicationType | Research Support, Non-U.S. Gov't | lld:pubmed |
